Department of Rheumatology & Immunology, the First Affiliated Hospital of Anhui Medical University, No. 218, Ji-Xi Road, Hefei, 230022, Anhui, China.
Department of Radiotherapy, the First Affiliated Hospital of Anhui Medical University, No. 218, Ji-Xi Road, Hefei, 230022, Anhui, China.
Eur J Med Res. 2024 Jan 20;29(1):61. doi: 10.1186/s40001-024-01665-2.
The objective of this study was to explore the associations of body mass index (BMI), fat mass index (FMI), skeletal mass index (SMI) and secondary osteoporosis (OP) in patients with rheumatoid arthritis (RA).
The bone mineral density (BMD) at sites of the femur neck (Neck), total hip (Hip) and lumbar vertebrae 1-4 (L1-4) was measured by dual-energy X-ray absorptiometry. The skeletal muscle index, body fat percentage and mineral content were measured by biological electrical impedance for calculating BMI, FMI and SMI.
A total of 433 patient with RA and 158 healthy controls were enrolled. The BMDs at each site of the RA patients were lower compared with those of the healthy controls (p < 0.0001), and the prevalence of OP (36.1%, 160/443) and sarcopenia (65.2%, 288/443) in the RA patients were higher than those in the controls (12.7%, 20/158, p < 0.0001; 9.0%, 14/156, p < 0.0001). Significant differences in the BMD, FMI, SMI, mineral content, body fat percentage and skeletal muscle mass were found among the RA patients in the different BMI groups (p < 0.05). In RA patients with BMI < 18.5 kg/m, the prevalence of OP in the RA patients with sarcopenia was similar to that in those without sarcopenia (44.4% vs. 66. 7%, χ = 0. 574, p = 0.449). In the RA patients with a normal BMI or who were overweight or obese, prevalence of OP in the RA patients with sarcopenia was significantly higher than that in the RA patients without sarcopenia (42.8% vs. 21.7%, χ = 10.951, p = 0.001; 61.1% vs. 13.0%, χ = 26.270, p < 0.0001). In the RA patients without sarcopenia, the prevalence of OP in the RA patients in the different BMI groups was different (p = 0.039). In the RA patients with sarcopenia, there was no significant difference in the prevalence of OP among the RA patients in the different BMI groups (p = 0. 128). The linear correlation analysis showed that the SMI in RA patients was positively correlated with the BMD of each site measured and BMI and FMI (p < 0.0001). However, there was a negative linear correlation between SMI and disease duration (p = 0.048). The logistic regression analysis found that SMI (OR = 0.569, p = 0.002, 95% CI 0.399-0.810), BMI (OR = 0.884, p = 0.01, 95% CI 0.805-0.971) and gender (1 = female, 2 = male) (OR = 0.097, p < 0.0001, 95% CI 0.040-0.236) were protective factors for OP in RA, while age (OR = 1.098, p < 0.0001, 95% CI 1.071-1.125) was the risk factor.
BMI and SMI are associated with the occurrence of OP in RA patients, and both SMI and BMI are important protective factors for OP secondary to RA.
本研究旨在探讨体质量指数(BMI)、脂肪质量指数(FMI)、骨骼质量指数(SMI)与类风湿关节炎(RA)患者的继发性骨质疏松症(OP)之间的关联。
通过双能 X 射线吸收法测量股骨颈(Neck)、全髋(Hip)和腰椎 1-4(L1-4)部位的骨密度(BMD)。通过生物电阻抗法测量骨骼肌指数、体脂肪百分比和矿物质含量,以计算 BMI、FMI 和 SMI。
共纳入 433 例 RA 患者和 158 例健康对照者。RA 患者各部位的 BMD 均低于健康对照者(p<0.0001),RA 患者的 OP(36.1%,160/443)和肌少症(65.2%,288/443)的患病率均高于对照组(12.7%,20/158,p<0.0001;9.0%,14/156,p<0.0001)。不同 BMI 组的 RA 患者的 BMD、FMI、SMI、矿物质含量、体脂肪百分比和骨骼肌质量存在显著差异(p<0.05)。在 BMI<18.5kg/m2的 RA 患者中,肌少症 RA 患者的 OP 患病率与无肌少症 RA 患者相似(44.4%比 66.7%,χ2=0.574,p=0.449)。在 BMI 正常或超重/肥胖的 RA 患者中,肌少症 RA 患者的 OP 患病率显著高于无肌少症 RA 患者(42.8%比 21.7%,χ2=10.951,p=0.001;61.1%比 13.0%,χ2=26.270,p<0.0001)。在无肌少症的 RA 患者中,不同 BMI 组的 RA 患者的 OP 患病率存在差异(p=0.039)。在有肌少症的 RA 患者中,不同 BMI 组的 RA 患者的 OP 患病率无显著差异(p=0.128)。线性相关分析显示,RA 患者的 SMI 与各部位测量的 BMD 以及 BMI 和 FMI 呈正相关(p<0.0001)。然而,SMI 与疾病病程呈负线性相关(p=0.048)。Logistic 回归分析发现,SMI(OR=0.569,p=0.002,95%CI 0.399-0.810)、BMI(OR=0.884,p=0.01,95%CI 0.805-0.971)和性别(1=女性,2=男性)(OR=0.097,p<0.0001,95%CI 0.040-0.236)是 RA 患者发生 OP 的保护因素,而年龄(OR=1.098,p<0.0001,95%CI 1.071-1.125)是 RA 患者发生 OP 的危险因素。
BMI 和 SMI 与 RA 患者 OP 的发生有关,SMI 和 BMI 都是 RA 继发 OP 的重要保护因素。